Total Payments
$7,393
2024 Payments
$124.95
Companies
39
Transactions
441
Medicare Patients
25,258
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$7,288 (98.6%)
Education$104.74 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,288 | 435 | 98.6% |
| Education | $104.74 | 6 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,016 | 66 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $936.18 | 47 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $716.37 | 49 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $694.03 | 35 | $0 (2024) |
| Amarin Pharma Inc. | $459.22 | 23 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $358.26 | 19 | $0 (2020) |
| Merck Sharp & Dohme LLC | $357.73 | 23 | $0 (2022) |
| Astellas Pharma US Inc | $352.46 | 18 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $348.80 | 19 | $0 (2019) |
| PFIZER INC. | $277.28 | 22 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.95 | 5 | Janssen Pharmaceuticals, Inc ($107.56) |
| 2023 | $221.29 | 6 | HeartFlow, Inc. ($131.43) |
| 2022 | $351.17 | 10 | Janssen Pharmaceuticals, Inc ($193.41) |
| 2021 | $257.60 | 12 | Janssen Pharmaceuticals, Inc ($137.13) |
| 2020 | $121.26 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($45.45) |
| 2019 | $1,947 | 117 | SANOFI-AVENTIS U.S. LLC ($299.49) |
| 2018 | $2,223 | 145 | AstraZeneca Pharmaceuticals LP ($293.77) |
| 2017 | $2,147 | 138 | SANOFI-AVENTIS U.S. LLC ($350.40) |
All Payment Transactions
441 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology | ||||||
| 04/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $131.43 | General |
| Category: Coronary | ||||||
| 03/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiology | ||||||
| 02/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/18/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiology | ||||||
| 07/30/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $45.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Cardiology | ||||||
| 06/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiology | ||||||
| 04/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/30/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 03/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2021 | BOSTON SCIENTIFIC CORPORATION | VARITHENA (Device) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Varithena | ||||||
| 10/28/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiology | ||||||
| 09/18/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 6,241 | 10,078 | $4.9M | $711,331 |
| 2022 | 37 | 6,314 | 10,852 | $5.2M | $743,200 |
| 2021 | 38 | 6,597 | 11,334 | $6.1M | $811,471 |
| 2020 | 35 | 6,106 | 9,884 | $5.6M | $715,842 |
Total Patients
25,258
Total Services
42,148
Medicare Billing
$3.0M
Procedure Codes
143
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 861 | 1,846 | $1.1M | $202,346 | 17.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 308 | 309 | $579,819 | $131,589 | 22.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 511 | 523 | $1.0M | $89,687 | 8.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 306 | 612 | $489,600 | $58,876 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 312 | 411 | $172,620 | $32,924 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 194 | 194 | $151,320 | $29,097 | 19.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 979 | 2,062 | $298,990 | $26,180 | 8.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 218 | 218 | $38,368 | $15,674 | 40.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 91 | 364 | $280,280 | $15,636 | 5.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 923 | 1,864 | $38,560 | $15,624 | 40.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 259 | 265 | $185,500 | $15,175 | 8.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 82 | 82 | $143,992 | $14,821 | 10.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $57,138 | $13,557 | 23.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 225 | 225 | $24,300 | $7,895 | 32.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 31 | 31 | $63,798 | $7,106 | 11.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $40,800 | $6,480 | 15.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 36 | 36 | $11,556 | $4,578 | 39.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $8,034 | $3,097 | 38.6% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 19 | 19 | $30,438 | $2,781 | 9.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 13 | 15 | $26,190 | $2,571 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $15,952 | $2,378 | 14.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 39 | 48 | $17,232 | $2,370 | 13.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $9,120 | $2,150 | 23.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 91 | 95 | $14,155 | $1,993 | 14.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 47 | $5,076 | $1,579 | 31.1% |
About Dr. William Blau, MD
Dr. William Blau, MD is a Cardiovascular Disease healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326084757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Blau, MD has received a total of $7,393 in payments from pharmaceutical and medical device companies, with $124.95 received in 2024. These payments were reported across 441 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,288).
As a Medicare-enrolled provider, Blau has provided services to 25,258 Medicare beneficiaries, totaling 42,148 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Great Neck, NY
- Active Since 06/22/2006
- Last Updated 02/25/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1326084757
Products in Payments
- Corlanor (Drug) $752.55
- XARELTO (Drug) $694.03
- PRALUENT (Drug) $570.42
- Vascepa (Drug) $459.22
- BRILINTA (Drug) $457.82
- MULTAQ (Drug) $365.76
- Repatha (Biological) $263.74
- FARXIGA (Drug) $257.76
- ELIQUIS (Drug) $246.33
- PRALUENT ALIROCUMAB INJECTION (Biological) $201.25
- JANUVIA (Drug) $183.22
- PRADAXA (Drug) $180.55
- JARDIANCE (Drug) $177.71
- BYSTOLIC (Drug) $172.12
- ENTRESTO (Drug) $164.02
- PRALUENT (Biological) $147.55
- FFRct (Device) $131.43
- WATCHMAN (Device) $113.62
- Livalo (Drug) $110.92
- PREVNAR - 13 (Biological) $105.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Great Neck
Dr. Evan Schwarzwald, D.o, D.O
Cardiovascular Disease — Payments: $449,880
Cardiovascular Disease $449,880
Dr. Steven Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $78,555
Cardiovascular Disease $78,555
Dr. David Stern, M.d, M.D
Cardiovascular Disease — Payments: $25,959
Cardiovascular Disease $25,959
Dr. Lauren Boglioli, Md Facc Facp Fccp, MD FACC FACP FCCP
Cardiovascular Disease — Payments: $15,130
Cardiovascular Disease $15,130
Dr. Joel Goldberg, Md, MD
Cardiovascular Disease — Payments: $8,960
Cardiovascular Disease $8,960
Navid Ahmed, M.d, M.D
Cardiovascular Disease — Payments: $8,200
Cardiovascular Disease $8,200